Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 409

The DOI matches its Crossref record.

HIV Controllers: A Homogeneous Group of HIV-1--Infected Patients with Spontaneous Control of Viral Replication

Lambotte, O., Boufassa, F., Madec, Y., Nguyen, A., Goujard, C., Meyer, L., Rouzioux, C., Venet, A., Delfraissy, J.-F., SEROCO-HEMOCO Study Group·2005·Clinical Infectious Diseases

Abstract

A small number of HIV-infected patients maintain high CD4+ T cell counts in the absence of antiretroviral therapy, despite a prolonged course of infection. These patients have been called long-term nonprogressors (LTNPs). The cause of the lack of disease progression in LTNPs is unclear, but long-term nonprogression seems to result from the interaction between factors linked to the virus (such as attenuation in HIV strains) or to the host [1]. Genetic susceptibility (e.g., the protective effect associated with the HLA B*5701 class I allele [2]) and the immune response (i.e., proliferation of HIV-specific CD8+ T cells and/or HIV-suppressive activity of CD8+ T cells) are involved [1, 3–5]. However, in contrast with data from basic science studies, demographic data for LTNPs are rare. Over time, the proportion of HIV-infected patients who are LTNPs progressively decreases, because of the progressive decrease of the CD4+ T cell count in some LTNPs [6]. The definition of LTNP, which is based on a high CD4+ T cell count, differs between studies and does not take into account the plasma HIV-1 RNA load [3, 4, 7–9]. For the majority of these patients, the plasma virus load is low, but the range is wide [3, 4, 9], and the decrease of the CD4+ T cells has been linked to high-level viremia [9]. In our clinical practice, we have observed patients in whom viral replication is spontaneously maintained below the lower limit of detection [10]. Therefore, we selected HIV-1—infected patients who had never received antiretroviral therapy and who had persistently maintained long-term control of HIV-1 viremia. The purpose of this study is to describe the frequency of this phenomenon among and the characteristics of those patients we have termed “HIV controllers.” Patients and methods. We defined an HIV controller as an HIV-infected patient who had been followed up for >10 years, who had received no antiretroviral treatment, and for whom >90% of the plasma HIV RNA load measurements were >400 copies/mL. CD4+ T cell count was not part of the definition. Among 1300 HIV-infected patients followed up in our department of infectious diseases (Centre Hospitalo—Universitaire de Bicêtre, Bicêtre, Assistance Publique—Hôpitaux de Paris), 8 met the above criteria (group A). We further extended our research to the French Agence Nationale de Recherche pour le SIDA et les Hépatites Virales SEROCO-HEMOCO cohort of 1551 HIV-infected patients that was initiated in 1988 [11]. In this cohort, 9 patients matched our definition of HIV controllers (group B), 2 of whom were followed up in our department and were included in group A. HIV DNA was quantified in PBMCs. One microgram of total DNA extracted from PBMCs was tested by means of a real-time PCR that targets a conserved region of the long terminal repeat region of the HIV-1 genome and had a sensitivity of 10 HIV-1 DNA copies per reaction [12]. Results were expressed as the number of HIV DNA copies per 106 PBMCs. HIV-specific CD8+ T cells were quantitated using an IFN-γ enzyme-linked immunospot (Elispot) assay, as described elsewhere [13]. Antigens consisted of peptides, distributed in pools, that corresponded to well-described optimal CD8+ T cell epitopes. The number of antigen-specific CD8+ T cells was expressed as the number of spot-forming cells (SFCs) per 106 PBMCs. To determine the HIV-specific CD4+ T cell response, lymphoproliferative responses to the p24 antigen were assessed by means of an IFN-γ Elispot assay [13]; data are specified as mean values ± SD. In addition, genotypic analysis of the gene encoding CCR-5 [11] and phenotypic analysis of the HLA class I alleles were performed. Results. Patients with HIV controller status were rare, comprising <1% of HIV-infected patients who were followed up in an infectious diseases department and/or were participating in the French prospective SEROCO-HEMOCO cohort, but the frequency of this condition was similar in each cohort. All patients had a positive HIV serologic titer. Their characteristics are given in table 1. All patients had stage A HIV infection, according to the Centers for Disease Control and Prevention classification, and were asymptomatic. Two patients had chronic hepatitis B, and 7 had chronic hepatitis C. Results of tests for detection of antiretroviral drugs in plasma specimens from patients in group A were negative. Characteristics of 15 patients in whom the plasma HIV RNA load has been undetectable for >10 years in the absence of antiretroviral treatment. The median CD4+ T cell count was 750 × 106 cells/L (range, 280–1398 cells/L) in group A and 750 × 106 cells/L (range, 332–1225 cells/L) in group B. Patients had a stable CD4+ T cell count over time: 3 had a CD4+ T cell count with a slope of 0 (mean change in the CD4+ T cell count, 0 ± 5 cells/year), 10 had a CD4+ T cell count with a slightly negative slope (mean decrease, 21 cells/year; range, 6–40 cells/year), and 2 had a CD4+ T cell count with positive slope (mean increase, 12

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/433188

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 409

Metadata

Authors
Lambotte, O., Boufassa, F., Madec, Y., Nguyen, A., Goujard, C., Meyer, L., Rouzioux, C., Venet, A., Delfraissy, J.-F., & SEROCO-HEMOCO Study Group
Venue
Clinical Infectious Diseases
Published
2005-10-01
Volume
41
Issue
7
Pages
1053-1056
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2110482783
Cited by
409
References
0
FWCI
3.85
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HIV Controllers: A Homogeneous Group of HIV-1--Infected Patients with Spontaneous Control of Viral Replication. https://app.cochat.ai/papers/10.1086/433188
The paper
Lambotte, O., Boufassa, F., Madec, Y., Nguyen, A., Goujard, C., Meyer, L., Rouzioux, C., Venet, A., Delfraissy, J.-F., & SEROCO-HEMOCO Study Group. (2005). HIV Controllers: A Homogeneous Group of HIV-1--Infected Patients with Spontaneous Control of Viral Replication. Clinical Infectious Diseases. https://doi.org/10.1086/433188

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.